Literature DB >> 3525433

Recombinant human tumor necrosis factor--I. Cytotoxic activity in vitro.

K Nakano, S Abe, Y Sohmura.   

Abstract

Cytotoxic activity of recombinant human TNF (rHu-TNF) on various human cell lines was examined in vitro. rHu-TNF exerted a cytostatic effect on various types of human tumor cells such as carcinoma, sarcoma, leukemia, melanoma and other types. When the cytocidal effect was examined on the tumor cells which were cytostatically susceptible to rHu-TNF, the cytocidal effect of rHu-TNF was also noticed on many of these tumor cells. However, some tumor cells were affected cytostatically only. Human diploid cells were not affected cytostatically or cytocidally by rHu-TNF. WI-38 VA13 cells which are an SV-40-transformed derivative of WI-38 diploid cells, were affected both cytostatically and cytocidally by rHu-TNF. These results suggest that rHu-TNF exerts cytostatic and cytocidal effects against a broad spectrum of human tumor cells, and its cytotoxic activity is tumor-specific.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525433     DOI: 10.1016/0192-0561(86)90117-7

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  13 in total

1.  Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor.

Authors:  M L Casey; S M Cox; B Beutler; L Milewich; P C MacDonald
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

2.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

3.  Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells.

Authors:  P A van de Wiel; R H Pieters; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.

Authors:  Y Nio; J Zighelboim; J S Berek; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Macrophage-activating factor extracted from mycoplasmas.

Authors:  M Takema; S Oka; K Uno; S Nakamura; H Arita; K Tawara; K Inaba; S Muramatsu
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Phase 2 trial of recombinant tumor necrosis factor-alpha in combination with dactinomycin in children with recurrent Wilms tumor.

Authors:  Holly J Meany; Nita L Seibel; Junfeng Sun; Jerry Z Finklestein; Judith Sato; John Kelleher; Paul Sondel; Gregory Reaman
Journal:  J Immunother       Date:  2008-09       Impact factor: 4.456

7.  Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells.

Authors:  Y Nio; J Zighelboim; J Berek; B Bonavida
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Interaction between endotoxin and the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in the induction of tumour necrosis factor and haemorrhagic necrosis of colon 38 tumours.

Authors:  L M Ching; W R Joseph; L Zhuang; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Effect of tumour necrosis factor and lipid A on functional and structural vascular volume in solid murine tumours.

Authors:  P A van de Weil; G J Bouma; A van der Pijl; E S Weitenberg; A W Lam; N Bloksma
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

10.  Potentiation of in vivo antitumor effects of recombinant interleukin-1 alpha by gelatin conjugation.

Authors:  Y Tabata; K Uno; Y Ikada; T Kishida; S Muramatsu
Journal:  Jpn J Cancer Res       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.